Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (391-400 of 659) with videos related to

Pageof 66
Sort By:
BMC Pregnancy and Childbirth|April 4, 2025
Maternal telomere length and oxidative stress in pregnancy: cross-sectional analysis with an exploratory examination of systemic inflammationLaura Etzel, Qiaofeng Ye, Abner T Apsley, et al.
Leukemia & Lymphoma|August 9, 2025
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phaseOmer Karrar, Hagop Kantarjian, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaWei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
British Journal of Pharmacology|December 22, 1999
Pharmacological characterization of antagonists of the C5a receptorN J Paczkowski, A M Finch, J B Whitmore, et al.
American Journal of Hematology|November 6, 2018
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American expertsNicholas J Short, Elias Jabbour, Maher Albitar, et al.
Chronic Illness|April 20, 2023
Perceptions of mindfulness practices as a support for individuals managing caregiving responsibilities and chronic disease: A qualitative studyNathan T West, Brook E Harmon, Kristen E Rawlett, et al.
Journal of Hematology & Oncology|May 14, 2025
Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomabNicholas J Short, Hagop Kantarjian, Ken Furudate, et al.
American Journal of Hematology|June 23, 2021
Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER studyElias Jabbour, Keyur Patel, Nitin Jain, et al.
Scientific Reports|July 23, 2024
Intergenerational effects of racism on amygdala and hippocampus resting state functional connectivityT R A Kral, C Y Williams, A C Wylie, et al.
Cancer|February 21, 2025
Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaEitan Kugler, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 66

Showing results (391-400 of 659) with videos related to

Sort By:
Pageof 66
BMC Pregnancy and Childbirth|April 4, 2025
Maternal telomere length and oxidative stress in pregnancy: cross-sectional analysis with an exploratory examination of systemic inflammationLaura Etzel, Qiaofeng Ye, Abner T Apsley, et al.
Leukemia & Lymphoma|August 9, 2025
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phaseOmer Karrar, Hagop Kantarjian, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaWei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
British Journal of Pharmacology|December 22, 1999
Pharmacological characterization of antagonists of the C5a receptorN J Paczkowski, A M Finch, J B Whitmore, et al.
American Journal of Hematology|November 6, 2018
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American expertsNicholas J Short, Elias Jabbour, Maher Albitar, et al.
Chronic Illness|April 20, 2023
Perceptions of mindfulness practices as a support for individuals managing caregiving responsibilities and chronic disease: A qualitative studyNathan T West, Brook E Harmon, Kristen E Rawlett, et al.
Journal of Hematology & Oncology|May 14, 2025
Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomabNicholas J Short, Hagop Kantarjian, Ken Furudate, et al.
American Journal of Hematology|June 23, 2021
Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER studyElias Jabbour, Keyur Patel, Nitin Jain, et al.
Scientific Reports|July 23, 2024
Intergenerational effects of racism on amygdala and hippocampus resting state functional connectivityT R A Kral, C Y Williams, A C Wylie, et al.
Cancer|February 21, 2025
Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaEitan Kugler, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 66